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We explored contraceptive use among 45 women who inject drugs in Coastal Kenya. Overall, 
29% were using contraceptives, motivated by a fear of unplanned pregnancy, a desire to 
shield children from the difficulties of drug use, the need to prevent HIV and other sexually 
transmitted infections, encouragement from health providers and outreach workers, or 
because they had achieved the desired number of children. However, 69% were not using 
contraceptives. Barriers to use included: current pregnancy intentions, perceived infertility 
due to drug induced-amenorrhea, side-effects, intimate partners’ influence, lack of 
information, complex healthcare appointments, and transport costs. Rights-based integration 
of sexual and reproductive health into harm reduction services for women who inject drugs is 
required to minimize unmet contraception needs. 
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People who inject drugs are a priority population for public health interventions, 
particularly HIV prevention. There are over 16 million people who inject drugs globally, of 
whom 3 million are infected with HIV (Mathers et al., 2008). Global health organizations 
recommend providing a package of harm reduction and HIV prevention interventions for all 
injecting drug users. This package includes needle and syringe exchange programs (NSPs), 
opioid substitution therapy with methadone (OST), and prevention and treatment of a range 
of infections including HIV, and other sexually and non-sexually transmitted infections 
(WHO, UNODC, & UNAIDS, 2009).  
Over the last few years, remarkable progress has been made in providing these 
services for people who use drugs globally (Degenhardt et al., 2014). However, significant 
coverage gaps persist, particularly in low and middle-income countries (Mathers et al., 2010). 
In particular, women who inject drugs are inequitably reached with harm reduction services 
(Page et al., 2015; Springer et al., 2015). There are an estimated 3.5 million women who 
inject drugs worldwide (Azim, Bontell, & Strathdee, 2015; Des Jarlais, Feelemyer, Modi, 
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Arasteh, & Hagan, 2012), and a significant majority of them are of reproductive age. 
However, compared to men, women who inject drugs are less likely to access drug treatment  
(Greenfield et al., 2007) and other health care services (Morrison, Ruben, & Beeching, 1995). 
Many of them engage in sex work to support their own and their partners’ drug use, often 
without adequate condom use (Azim et al., 2015). In addition, women who inject drugs 
experience worse drug use-related stigma than men do (Azim et al., 2015; Khuat, Morrow, 
Nguyen, & Armstrong, 2015), especially when pregnant (Simpson & McNulty, 2008), and, 
as a result, they have sub-optimal utilization of prenatal care (Peters et al., 2003).  
Evidence suggests that most women who inject drugs, including those in harm 
reduction programs, often have unaddressed reproductive health needs (Black, Stephens, 
Haber, & Lintzeris, 2012; Harding & Ritchie, 2003; Morrison et al., 1995), including 
contraception (Black et al., 2012). Studies suggest that the broader reproductive health needs 
of women who inject drugs are often overlooked due to a narrow focus on HIV prevention 
(Sherman, Kamarulzaman, & Spittal, 2008) and a failure to integrate wider health needs into 
drug treatment programs (Pinkham, Stoicescu, & Myers, 2012). As a result, the unique needs 
of women who inject drugs, including sexual and reproductive health, are rarely responded to 
in harm reduction programs (Pinkham & Malinowska-Sempruch, 2008; Pinkham et al., 2012; 
Tuchman, 2010). 
However, understanding and addressing the sexual and reproductive health of this 
population is important at two levels. At a macro level, it is central to the achievement of 
universal access to reproductive health and gender equity, which in turn contributes to the 
achievement of sustainable development goals (UNODC, 2016) and the International 
Conference on Population and Development’s (ICPD) recommendations (Cates & Maggwa, 
2014). At a micro level, understanding contraceptive needs, fertility-related behaviors, 
desired fertility, and other sexual and reproductive needs can inform women-centered 
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services. The need for gender-sensitive services is currently gaining visibility, with calls to 
integrate interventions that address the unique needs and vulnerabilities of women in harm 
reduction services (Ayon et al., 2017; El-Bassel & Strathdee, 2015; Ippoliti, Nanda, & 
Wilcher, 2017; Iversen, Page, Madden, & Maher, 2015; Pinkham & Malinowska-Sempruch, 
2008). 
In Kenya, harm reduction and drug treatment services are nascent (Rhodes, Closson, 
Paparini, Guise, & Strathdee, 2016): NSP and OST were incorporated within HIV and public 
health programs in 2013 (NASCOP, 2013). In this context, very few, if any, studies have 
been conducted on contraceptive use among women who inject drugs. However, information 
regarding contraception and other aspects of the sexual and reproductive health of women 
who inject drugs is particularly needed to inform facility- and community-based harm-
reduction service delivery models, many of which are in development (Ayon et al., 2017; 
Rhodes et al., 2016). Here, we report patterns of contraceptive use among women who inject 
drugs in Kenya.  
Method 
Study Design  
Data reported here were generated as part of a large qualitative study whose aim was 
to explore the determinants of sexual and reproductive health among women who inject 
drugs. Specific objectives were to understand what the specific sexual and reproductive 
service needs of women who inject drugs are, and to explore determinants of access to sexual 
and reproductive health services in this population. Given the known complexity of the social 
contexts of women’s drug use, contraception, and parenting (Olsen, Banwell, & Madden, 
2014), qualitative explorations are particularly well suited to illuminate different perspectives 
related to the intersection of women’s drug use and reproduction. In the present study, we 
combined in-depth interviews (IDIs) and focus group discussions (FGDs) to gather 
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complementary information (Esterberg, 2002) and triangulated these with IDIs with key 
stakeholders involved in service provision to drug users. 
Study Setting 
The study was conducted in two Kenyan coastal towns: Mombasa and Kilifi. In these 
towns, community-based services for injecting drug users were being implemented by the 
Kenya AIDS NGOs Consortium (KANCO), a local non-governmental organization. The 
services were being provided through two community-based organizations (CBOs): Reach 
out Centre Trust (REACH OUT) and the Muslim Education and Welfare Association 
(MEWA). Beginning in 2012, these sites formed part of a pilot implementation of a new 
community-based harm reduction service-delivery approach. As opposed to relying on drug 
users to attend health facilities, outreach workers contact injecting drug users in their own 
localities to provide them with services and referrals to drop-in centers or tertiary health 
facilities (Ayon et al., 2017; Coyle, Needle, & Normand, 1998). The nature and scope of 
services provided to injecting drug users in the study context is shown in Table 1. 
Participants  
Participants were recruited via the above community-based organizations using 
convenience and purposive sampling strategies (Etikan, Musa, & Alkassim, 2016; Robinson, 
2014). Researchers (JN and SA) approached the organizations and explained the purpose of 
the study. Information sheets with detailed study information were provided to outreach 
teams, who then approached individual women during the course of their routine outreach 
and introduced them to the study. Those who were interested in taking part were screened for 
eligibility. To be included, participants had to be an adult aged at least 18 years, which is the 
legal age to provide independent consent; be aged 49 years or younger; and have a history of 
injecting drugs within the 90 days prior to participation in the study. Eligible participants 
were scheduled for IDI or FGDs. In addition to the women, a purposive sample of key 
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stakeholders were selected based on their policy or service expertise, in consultation with the 
two community based organizations. 
The final sample comprised of 45 women who injected drugs and five key 
stakeholders. Twenty-four of the women participated in IDIs (12 at each site), and 21 
participated in three FGDs: one session in Mombasa (n=5) and two sessions in Kilifi, (n=6 
and n=10, respectively). The five key stakeholders, of whom three were female, included a 
community health worker (n=1), outreach workers (n=2), a Ministry of Health official (n=1), 
and a CBO manager (n=1). The age of the 45 women participants ranged from 19 to 56 years, 
with an average age of 28.5 years. Thirty-seven of the women had at least one child (range 1–
5). The majority of women participants were single, without secondary or post-secondary 
education, and either unemployed or working in informal sector (See Table 2). 
Data Collection 
Data were collected in 2015 by two of the authors (JN and SA) who are experienced 
in conducting qualitative research. All IDIs and FGDs were conducted in Swahili, the 
national language, or English, depending on participants’ preferences. Data were collected in 
private rooms on the premises of the community-based organizations or in the offices of the 
key stakeholders. All IDIs and FGDs were audio recorded and lasted 45-60 minutes. At the 
end of the IDIs and FGDs, a brief, standardized set of questions was used to collect socio-
demographic data, such as age, education, marital status, religion, source of income, fertility, 
contraceptive use, and current living arrangements.  
Data Analysis 
Socio-demographic data were entered into Excel files and descriptive summaries 
generated. IDIs and FGDs were transcribed into English as needed. All transcripts were 
imported into Nvivo v.11 (Bazeley, 2007), and analyzed through an inductive thematic 
approach (Bryman, 2012). Transcripts were read and used to generate nodes in Nvivo. Nodes 
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were then populated with quotes from participants (Pope, Ziebland, & Mays, 2000). Codes 
were then refined through the constant comparison approach (Silverman, 2001) and 
categorized to generate themes (Charmaz, 2000).  
Ethical Considerations 
Participation in this study was voluntary, and a written informed consent was obtained 
from each study participant after they were provided with a detailed description of the study’s 
objectives and procedures. Data were collected in private rooms to safeguard confidentiality, 
and a token amount of Kenya Shillings (KES) 400 (the equivalent of four US dollars) was 
provided to participants. Ethical review and authorization for this research was provided by 
the National Commission for Science Technology and Innovation (NACOSTI). 
 
Results 
Use of Contraceptives 
Thirteen women (29% of the overall sample) were currently using contraceptives at 
the time of the study. These included traditional methods such as periodic abstinence, and 
modern methods such as implants. Sixty-nine percent (n=31) were not using contraception at 
the time of the study. Seven of the 13 women who were using contraceptives were sex 
workers, two were casual laborers or were involved in small businesses (e.g., kiosk or 
plaiting), and the remaining earned their income either through “hustling” (n=2) or begging 
(n=2). Six of the 31 women who were not using contraceptives were sex workers, 10 were 
either casual laborers or were involved in small businesses (e.g., kiosk or plaiting), four 
depended on their partners or spouses for income, and the remaining earned their income 
either through peddling (n=3), “hustling” (n=2), begging (n=5), or as a peer-educator (n=1). 
All of the six participants who reported relying on condoms were sex workers (See Table 3).   
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Motivations for Contraceptive Use 
The prospect of ideal motherhood and childrearing provided at least 10 women with 
an incentive to start using contraception. Narratives from the women who were using 
contraceptives indicated that they understood the responsibilities of motherhood and 
childrearing, and many believed that they could be capable parents, except for their drug use. 
It was clear that the fear of unplanned pregnancy motivated these women’s contraceptive use, 
as exemplified by the following quote: 
Life is hard, you can’t get pregnant and be able to take care of the child when you are 
still a drug user. (Participant # 5, Kilifi) 
The above participant was one of the 37 women who already had a child. They said that, 
although they were in difficult circumstances, contraception allowed them to plan a 
pregnancy and fulfil their aspirations of motherhood: 
So for me those are my reasons for family planning. When someone is ready, you just 
go and get it removed, then after 1 month you are good to have a baby, rather than 
have a baby that you are not expecting. (Participant # 1, Kilifi) 
In other cases, motivation for using contraception emanated from the fact that women 
had already achieved their desired fertility or family size. Asked about her decision to use 
injectable contraceptives, one participant remarked: 
I am using the injection. I decided to on my own, because I have three children. I 
don’t want to add a fourth one. The last one I was not expecting. (Participant # 7, 
Kilifi) 
As can be noted from the above excerpt, current use of contraceptives was often driven by 
past experiences of having conceived unexpectedly. In other cases, women were conscious of 
their social contexts and attempted to shield their children from the difficulties associated 
with drug use. At least 10 participants were cognizant that their ability to parent a child was 
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threatened by economic hardships. In this context, their drug use was itself a primary 
motivator for contraceptive use: 
I thought, ‘hey, I have got all these children that I had not planned for, so I am better 
off having this implant so that I don’t get a child that I will cause to suffer.’ 
(Participant # 1, Kilifi) 
Another incentive to use contraception was to prevent infections. Participants 
recognized the dual protection benefits of condoms related to both contraception and 
prevention of sexually transmitted infections (STIs). As a participant explained: 
First of all, the condoms help a lot. They protect from gonorrhea and many infections 
All these means of family planning really help to prevent from unwanted babies and 
unplanned pregnancies. (Participant # 1, Kilifi)  
Another participant, who was living with HIV, suggested that she used condoms to prevent 
transmitting HIV infection to others and, at the same time, to prevent super-infection with 
other strains of the HIV virus. Asked about her motivations, she remarked: 
To protect myself. So that I don’t transmit my own and don’t affect the others and 
stay with my own type of HIV virus. (Participant # 11, Kilifi)  
Given her emphasis on the benefit of condom use for preventing infections, she was 
questioned about whether this is the main use of condoms, to which she highlighted dual 
benefits “to protect against diseases and pregnancy” (Participant # 11, Kilifi). 
Another motivation of several participants living with HIV pertained to prevention of 
mother to child transmission of HIV. Asked about her reasons, one HIV-positive participant 
remarked that she was using contraceptives due to “this disease I am having. These days 
when you give birth you are told if you have it [HIV] you are to use a family planning 
method” (Participant # 5, Kilifi). Attitudes toward contraception were intertwined with this 
participant’s concern about her own health. Advice from health providers facilitated this 
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participant’s decision; she remarked that “according to the doctor…my immunity is still low” 
and, in her view, she was not in good health, and therefore chose to use contraceptives.  
Another motivator for use of contraceptives was participants’ interactions, acceptance 
or encouragement by facility-based health providers and outreach workers. Health providers 
particularly encouraged injecting drug users to use contraceptives. Women pointed out that 
they experienced positive attitude from health providers when they sought contraception 
compared to any other service. Asked about her experience and interaction with healthcare 
providers of contraception services at one of the referral hospitals, one respondent remarked: 
They treat you well, because you have come to get family planning medications. They 
also encourage us to bring a friend along to get family planning services. (Participant 
# 7, Kilifi). 
Although findings suggested a bias towards providing contraception in particular, positive 
attitudes towards women were said to have resulted from training and sensitization of 
healthcare providers regarding the needs of women who inject drugs. Initially, interactions 
were said to have been negative because “the health care workers did not understand why and 
how they needed to serve female drug users” (Stakeholder # 3, Kilifi). However, following 
training of healthcare providers, their interactions with women improved. Our data suggest 
that outreach workers play a mediatory role of sensitizing healthcare providers, especially 
when they accompanied women to health facilities: 
If you say to the outreach worker: “How can I access family planning services?”, they 
say: “Come tomorrow I’ll take you the hospital.” They don’t leave us behind 
(Participant # 10, Mombasa). 
In these instances, a participant mentioned that it was outreach workers who “will be in front 
at the doctor”. She elaborated that outreach worker would “talk” and explain their health 
needs to health providers (Participant # 5, Kilifi). Indeed, narratives suggest that women first 
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started using contraceptives as a result of interaction and information acquisition from 
outreach teams. Information from outreach workers was highly valued. One participant, who 
referred to the role of outreach teams specifically in shaping her decision to use 
contraceptives, said: “you know I was once a peer educator; they teach us” (Participant # 6, 
Mombasa). In addition, a participant pointed out that “outreach workers usually give us 
condoms for our safety” (Participant # 7, Mombasa). Although this condom provision might 
have been primarily driven by the need to prevent HIV, condoms were often used to prevent 
unwanted pregnancies as indicated in Table 3. 
Barriers to Use of Contraceptives 
Narratives from the eight women who did not have a child revealed deeply held 
aspirations of motherhood and desire for a future pregnancy. Yet, amidst the hope of 
achieving motherhood, virtually all of these women expressed disappointment that they could 
not conceive because of their ongoing drug use. One participant remarked: 
I would want to have children, but I don’t know what the problem is; is it my 
reproductive organs, or these drugs that I am using? (Participant # 3, Kilifi) 
However, majority of participants who were not using contraceptives had not made a 
deliberate choice, but were not using contraceptives due to a variety of reasons. Three women 
attributed their failure to use contraceptives – when they had intended to use them – either to 
forgetfulness, or to not being organized enough to follow-up on their appointments. Asked 
why she did not keep her appointments, one participant explained: 
It is heroin; heroin causes all this. Even seeking for health services? ahh! I just keep 
thinking I’m alright. I don’t even make follow-ups. (Participant # 9, Kilifi) 
Questioned further, this participant noted the apparent incompatibility of keeping 
appointments with ongoing drug use: “after stopping these drugs is when I can follow-up on 
services. Without stopping drugs, there is nothing I can follow-up on” (Participant # 9, 
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Kilifi). Forgetfulness was blamed for failure to keep appointments, as noted in the case of 
another participant: 
I have a Norplant, but it requires to be removed this year. The card got lost, and I 
can’t remember which month it is supposed to be removed.  Now I see as if it is past 
the due date. (Participant # 1, Kilifi) 
Other barriers were related to the health system. For instance, when questioned 
further, the above participant’s account suggested that strict scheduling of family planning 
services makes it impossible to access them: 
I went last week…first they gave me a date that was the following day. On the day, I 
remembered when it was late, because when it gets to past 12 noon, they normally 
would have left, those people for ‘Tupange’ [family planning program]. Now they 
told me there is another date, so I’m now waiting for the next date, although I have 
not confirmed on what day it will be, but I will go there today to confirm. (Participant 
# 1, Kilifi) 
Transport costs were a contributing factor to low contraceptive use by these women. 
In the words of one, “getting time to go to other hospitals and use money for receive family 
planning services” prevented her use of contraceptives (Participant # 9, Mombasa). Asked for 
her opinion about how family planning and other related services could be ideally provided to 
her and other persons who use drugs, another participant said that “first of all, they need to 
bring the service here because many women are lazy to go there [health facility]; sometimes 
they lack fare. It [family planning service] should be brought here to this drop-in center.” 
(Participant # 1, Kilifi)  
Another reason for not using contraception was a perceived infertility due to 
amenorrhea. The potential of drug use to cause amenorrhea was central to women’s attitudes 
toward contraception, as many speculated that their need for contraception was nullified by 
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the amenorrhea. This belief reduced their uptake of most contraceptives, with the possible 
exception of condoms. Virtually all interviewed women had experienced amenorrhea 
associated with their drug use. When questioned about her experience of amenorrhea, one 
respondent commented that her lack of periods was “a result of using drugs” and stated that 
her drug use “has become my way of family planning, although I have not fully understood 
it” (Participant # 3, Kilifi). It is not surprising that such participants determined that as long 
as they used drugs, they were unlikely to conceive: 
Given the way in which I am using [drugs], I don’t think that I will get pregnant any 
time soon. (Participant # 3, Kilifi) 
For at least two experienced users, drug-induced amenorrhea was the main method of 
managing potential conception. This was the case for one older woman, who had spaced her 
four children by varying her drug use pattern: 
The drug makes one not to conceive, you see. If I inject a certain quantity of drug, I 
know I won’t get pregnant. If I reduced to another particular quantity, I know I will 
get pregnant. That is how I do family planning. (Participant # 9, Mombasa) 
However, for the most part, amenorrhea caused frustration among participants who were 
planning to get pregnant: 
I have stayed and stayed, and I have not gotten pregnant; I have gotten late, and I am 
not getting pregnant. I hear that when we use drugs, it is said that it usually prevents 
someone from getting pregnant…It usually prevents us from getting periods, and 
when you have periods you have very bad cramps, it is so painful. Other times it can 
take more than 2 years before you have periods. I don’t know what it is usually 
happening. (Participant # 8, Kilifi)  
Interpretations of this phenomenon were diverse but often linked to infertility. For example, 
one women suggested that her “womanhood is so deeply located” apparently because “before 
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I even conceived my first child, I waited for so long; I thought I was barren” (Participant # 
11, Kilifi). She elaborated further by stating that “I thought I was barren, I waited for so long. 
I left school, stayed with a man, left the man, stayed with another man, left again and I only 
came to conceive with the third man” (Participant # 11, Kilifi).  
Among those who had a history of contraceptive use, adverse side effects were a 
significant cause of concern and a barrier to the use of contraception, especially hormone-
based methods. In an uncommon response, a participant voiced these concerns by mentioning 
that she was lucky not to have experienced adverse side effects. While “some makes your 
heart beat fast, and feel like vomiting. I am grateful this is working well with me; I don’t 
have any complications” (Participant # 7, Kilifi). Asked about her use of injectable 
contraceptives, another participant from Kilifi described experiencing “side effects such as 
difficulty in breathing, and weight gain” following which she “decided to leave them alone” 
(Participant # 9, Kilifi).  
Unfortunately, these side effects often made women not want to use any method at 
all, not even to switch to another method. One participant, responding to a question about her 
experience of raised blood pressure, stated that: 
I was given an injection that brought complications. The medicine was changed and 
the next one also brought complications. I saw it would finish me very fast, so I left it. 
I totally stopped [family planning]. (Participant # 9, Kilifi)  
At least two other participants from Mombasa had stopped using the contraceptive pill and 
injectable contraceptives, respectively, due to menorrhagia. One remarked that “you know 
these pills also have side effects; you can you bleed the whole year” (Participant # 7, 
Mombasa), and the other said that “when I started injection for family planning, I was having 
periods throughout, so I stopped” (Participant # 6, Mombasa). 
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Influence by an intimate partner only rarely determined women’s non-use of 
contraception. For instance, one participant remarked that “I was using a coil, and then my 
boyfriend said it was hurting him, and I was also having abdominal cramps. So I went and 
removed it” (Participant # 10, Kilifi). More commonly, gender relations played out in 
condom use in the context of sex work. Here, inability to negotiate for condoms suppressed 
use of condoms because in the words of one participant, “there are other [clients] I have met - 
they don’t want a condom; 100% they don’t want condoms” (Participant # 7, Kilifi). 
Finally, although availability of information was a facilitator, the lack of it seemed to 
contribute directly to the low contraceptive use. Most women were only familiar with the 
contraceptives they were using, and most seemed unaware of the wide variety of 
contraception methods. For example, when asked which contraception methods she knew, 
one participant said that she did not know “because I don’t use any” (Participant # 12, Kilifi). 
Another participant responded that she was not using contraception because “I don’t have the 
information about those things” (Participant # 6, Mombasa) (See Table 4.)  
Unplanned Pregnancies and their Outcomes 
No participant described becoming pregnant while on contraception. However, given 
the range of barriers, it is not surprising that there were a number of unplanned pregnancies. 
Typical descriptions of these by participants were that they “got pregnant without planning” 
(Participant # 7, Kilifi) or that they “had not intended, it was accidental” (Participant # 11, 
Kilifi). A number of participants reported having conceived when they did not desire to 
become pregnant but had either not used contraceptives, or had missed taking them for some 
days. Some of them reported having realized they were pregnant quite late: 
I discovered when I was already 5 months pregnant because I usually have irregular 
periods. I was just shocked to learn that I was pregnant, because I had only skipped a 
day without going for the injection. (Participant # 10, Mombasa) 
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Accounts from at least two women highlight the realities associated with unintended 
pregnancy. Upon realization that they were unexpectedly pregnant, some opted to carry the 
pregnancy to term, and others opted for abortion, with varied results. Within this context 
there were strong themes related to the influences of intimate partners on the potential 
termination of pregnancy: 
After 3 months I got pregnant. You know we had not planned anything. I saw that he 
had changed. They made me to abort that pregnancy. (Participant # 11, Kilifi) 
In other situations, women used herbal and other abortifacients, often unsuccessfully. One 
participant discussed how she had attempted unsuccessfully to terminate her pregnancy: 
I was surprised that the pregnancy was already 4 months. I panicked and did not know 
what to do, so I smoked Bugizi and injected drugs. Then I thought she was dead. But 
she never died, here she is, growing up. (Participant # 10, Mombasa) 
Discussion 
Understanding the contraceptive use and pregnancy intentions of women who inject 
drugs is critical in addressing unmet contraception needs, preventing unplanned pregnancies, 
and improving their health and that of their children. To our knowledge, this is the first study 
to assess contraceptive use among women who inject drugs in Kenya. Our study provides 
important findings related to the motivations, barriers, and potential unmet needs among this 
population, and the results highlight the highly contextual emotional, physiological, gender, 
and structural factors that affect decision making regarding fertility and pregnancy intentions. 
Several findings warrant policy and program attention. 
The first concerns unmet contraceptive needs. Our participants reported several 
unplanned pregnancies, as well as abortions, which points to unmet contraception needs. 
Pregnancies ending in abortion are generally assumed to have been unintended (Santelli et 
al., 2003). These findings are in line with findings from a recent systematic review that 
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reported high unmet contraceptive needs, especially for the most effective methods, among 
women who use drugs globally (Terplan, Hand, Hutchinson, Salisbury-Afshar, & Heil, 
2015). It is not surprising that women who use drugs are more likely than non-drug-using 
women to have unplanned pregnancies (Than et al., 2005).  
In Kenya, contraceptive prevalence is around 47% (Tumlinson, Pence, Curtis, 
Marshall, & Speizer, 2015), which suggests a substantial level of unmet family planning 
needs among all women of reproductive age. Our results suggest that women who inject 
drugs may have an even higher level of unmet contraceptive need. The utilization of effective 
long-acting methods, such as intra-uterine devices (IUDs) and implants, was particularly 
limited. Studies from other countries have also shown very low prevalence of reliable 
contraception and high levels of unplanned pregnancies among women who inject opioid and 
other drugs (Heil et al., 2011; Ralph & Spigner, 1986; Weber et al., 2003). Taken together 
with existing literature from other countries, our findings point to a substantial unmet 
contraception need in women who inject drugs at the Kenyan coast. 
The second finding relates to the role of drug use in influencing contraception uptake. 
Although there was a desire to limit births among the majority of participants who already 
had children, participants recognized that their ability to parent a child was threatened by 
their drug use and social context, which was economically deprived. At the same time, drugs’ 
association with amenorrhea and dysmenorrhea, a phenomenon well documented in 
international literature (Harding & Ritchie, 2003; Olsen et al., 2014) was cited as a reason for 
not using contraception. In our study, participants frequently interpreted their amenorrhea or 
dysmenorrhea as infertility, as is the case in other contexts (Olsen et al., 2014). In sum, drug 
use was both a primary motivator and a barrier for contraceptive use.  
Third, our data show that most women had made deliberate decisions regarding future 
pregnancy intentions, and they were trying to conceive or to prevent conception with valid 
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reasons, which contradicts notions that women who inject drugs are unable to make logical 
decisions about their fertility. Similar observations were made by Olsen et al. (2014) who 
found that women drug users in Australia had high levels of agency, and made informed 
decisions regarding contraception, pregnancy and parenting. Additionally in our study, HIV 
positive women made deliberate attempts to use condoms consistently, similar to 
observations from other countries showing that HIV positive injecting drug users take into 
account the risk of HIV transmission in their contraceptive practices, and are often more 
likely than the general population to use male condoms (Vidal-Trecan et al., 2003).  
The fourth finding relates to barriers to contraception uptake. Our data corroborate 
findings from other studies regarding the importance of a range of barriers, such as the 
infertility beliefs mentioned above (White, Phillips, Mulleady, & Cupitt, 1993), contraception 
side effects (Harding & Ritchie, 2003), transport costs, experiences with health care provision 
(Armstrong, Kenen, & Samost, 1991), influence from intimate partners, forgetfulness, 
convenience (Egarter et al., 2013), influence from intimate partners, and difficulty 
negotiating condom use with sexual partners (Ippoliti et al., 2017; White et al., 1993). Most 
of these factors are not necessarily unique among women who inject drugs, as they are also 
observed among women who do not use drugs (Ippoliti et al., 2017; Peipert, Madden, 
Allsworth, & Secura, 2012; Wulifan, Brenner, Jahn, & De Allegri, 2016). However, some of 
these barriers may affect this population in a unique way. For instance, waiting in a queue for 
contraception can arguably be challenging for someone experiencing withdrawal symptoms, 
and, as noted in our study, some women simply left facilities when they sensed these 
symptoms. Although addressing all barriers is important, considering the unique nature of the 
challenges among women who use drugs will be essential to the success of potential 
interventions.  
The fifth finding relates to the service model of providing contraception to women 
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who inject drugs. Our study shows the value of an outreach approach for women who inject 
drugs in the study context, which is documented in depth elsewhere (Ayon et al., 2017). 
Apart from hospitals and peers, outreach workers were mentioned as a source of important 
information and referrals related to sexual and reproductive health, including contraception. 
Community-based outreach workers provided women with contraceptive pills and condoms. 
However, provision of long acting reversible contraceptives, such as IUDs and implants to 
drug users in their own localities was limited, and they had to be referred to specialized 
services by community-based outreach teams. Nevertheless, our findings suggest that 
integrating programs and interventions to prevent unintended pregnancies into outreach-
based harm reduction programming is acceptable to women who inject drugs. Moving 
forward, women who inject drugs will need to be informed of all potential contraception 
options, and these methods must be brought closer to this population. Because uptake of 
contraception increases when more methods are available to potential users (Ross & Stover, 
2013), both community-based distribution and drop-in centers should be utilized to ensure 
that a wide range of contraceptives is made available. For instance, implants and IUDs could 
be provided at drop-in centers as part of harm reduction services.  
Other researchers in countries with advanced responses to women who inject drugs 
have argued that offering contraception services in conjunction with substance use harm 
reduction programs is essential to reduce unintended pregnancy in this population (Black et 
al., 2012; Terplan et al., 2015). This requires a conscious expansion of the scope of harm 
reduction programs to include sexual and reproductive health services, especially for women 
(Malinowska-Sempruch, 2015; Morrison et al., 1995). As Black et al. (2012) argued, 
integrating these services could improve contraceptive uptake due to the familiar non-
threatening environment of harm reduction programs.  
Ensuring that services are provided in spaces that women are familiar and 
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comfortable with is particularly important given that attitudes of health providers affect 
women’s access and uptake of sexual and reproductive health services (Armstrong et al., 
1991; Ippoliti et al., 2017). In the areas where our study was conducted, the outreach program 
was expanded in 2014 to include sexual and reproductive health services, and this was 
accompanied by sensitization of health providers in facilities where referrals are made to 
mitigate stigmatizing attitudes towards women who inject drugs. Eliminating stigma and 
gender discrimination is a critical step toward achievement of the commitment contained in 
the ICPD Program of Action. Adopted in 1994 by 179 UN Member States, the ICPD 
Program of Action aims to advance the sexual and reproductive health and rights of all 
individuals (Barroso, 2014). 
Finally, the confluence of drug use and sex work interfered with consistent use of 
condoms, which suggests that skills for condom negotiation would be useful, and it is 
important to recognize that sex work can occur in intoxicated states or alongside drug 
injecting. The promotion of dual method contraception use is particularly needed to mitigate 
the risk of HIV and other STIs. Although the risk of HIV among injecting drug users is not 
necessarily surprising, when considered in the context of unplanned pregnancies, it raises 
concerns related to child care and prevention of mother to child transmission. Women with 
unplanned pregnancies are less likely than those with intended pregnancies to seek antenatal 
care (Cheng, Schwarz, Douglas, & Horon, 2009), and they are more likely to use drugs (Dott, 
Rasmussen, Hogue, & Reefhuis, 2010). In addition, regardless of pregnancy intentions, 
mothers’ preexisting physical and socioeconomic status has a significant impact on post-natal 
child health and well-being (Howell, Heiser, & Harrington, 1999). Together, participants’ 
socio-economic and HIV risk contexts suggest that avenues to increase condom use, 
including female condoms, should be explored regardless of their use of other contraceptives. 
At the same time, research should be done on the outcomes of children of women who inject 
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drugs, as has been advocated by other researchers (Pinkham & Malinowska-Sempruch, 
2008). 
Limitations 
Before firm conclusions can be made, limitations of the present study should be 
noted. To begin, we did not plan to provide precise estimates of unmet contraceptive needs. 
However, our data show unmet needs and the context within which these needs occur. In 
addition, it is possible that social desirability bias influenced participants’ comments. Finally, 
our study included participants who were in contact with an outreach-based harm reduction 
program, thus their healthcare seeking behaviors may differ with those without such contact 
(Coyle et al., 1998). 
Conclusion 
This article documents motivators, barriers, and unmet contraceptive needs among 
women who inject drugs at the Kenyan coast; our results add weight to global calls to 
advance the sexual and reproductive health and rights of all individuals, including women 
who inject drugs. Overall, 29% of women in this study were using contraceptives, motivated 
by a fear of unplanned pregnancy, desire to shield children from difficulties of drug use, 
prevention of HIV and sexually transmitted infections, encouragement from health providers 
and outreach workers, or having achieved the desired number of children. However, 69% 
were not using contraceptives, mainly due to current pregnancy intentions, perceived 
infertility from drug induced-amenorrhea, side-effects from contraceptives, intimate partners’ 
influence, lack of information, complex healthcare appointments, and transport costs. Our 
participants reported unplanned pregnancies, as well as abortions, which suggests an unmet 
need of contraception. 
These findings have practical implications and primarily suggest that integrating 
sexual and reproductive health services, including contraceptives, into drug-use treatment and 
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other harm reduction services, is a feasible and acceptable approach to meeting the unique 
needs of women who inject drugs. Community-based distribution of contraceptives through 
outreach should be complemented with contraceptive services at both drop-in centers and 
conventional health facilities; and the ongoing sensitization of healthcare providers is also 
necessary. Although choice of approach may differ based on context and acceptability, it is 
essential to provide a wide range of contraceptive choice suitable to the preference and 
medical eligibility of each drug-using woman, within a rights-based approach.  
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Table 1. Services provided to women who inject drugs at the study sites 
 
Service domain Interventions and services 
provided during outreach 
Interventions and 
services provided at 
drop-in centres 
Referrals to private and 
government health and 
social services 
Prevention and 
treatment of HIV 
and co-infections  
Condoms, HIV testing, 
information, communication 
and education on HIV and 
sexually transmitted 
infections. 
HIV testing and 
counselling.  
Referral for confirmation 
and treatment of HIV, 
and screening of Hepatitis 
C and Tuberculosis. 
Harm reduction Clean needle and syringes, 
alcohol swabs, cotton wool. 
Addiction counseling and 
first aid for violence and 
overdose. 
Referrals for medically 





Information on family 
planning, sister-to-sister 
counselling, hygiene 
packages/tampons and oral 
contraceptive pills. 
Pre-natal education, and 
provision of short-acting 
reversible contraceptives.  
Referral for long-acting 
long-acting reversible 
contraception, ante-natal 
care, and screening for 
cervical cancer. 
Personal, social 
and child care 
services 
Transportation to health 
facilities and provision of 
personal care items. 
Personal care (shower, 
toothbrush/paste, lotion), 
short-term shelter, and 
diapers for children. 
Referrals for sexual 





Table 2. Participant characteristics  
Characteristic IDI (n=24) FGDs (n=21) 
Total 
(n=45) % 
Age mean years, (SD) 26.4 (7.3) 30.5 (5.8) 28.4 (8.5) - 
Number of children, mean (SD) 1.5 (1.4) 1.9 (1.2) 1.6 (1.33) - 
Education 
None 4 4 8 18% 
Primary  13 10 23 51% 
Secondary 6 6 12 27% 
Post-secondary 0 1 1 2% 
Unknown 1 0 1 2% 
Marital status 
Married 5 3 8 18% 
Live in partner 7 5 12 27% 
Single 11 13 24 53% 
Unknown 1 0 1 2% 
Income source 
Casual labor 2 5 7 16% 
Food Kiosk/plaiting 3 2 5 11% 
Sex work 9 4 13 29% 
Peddling 1 2 3 7% 
Peer educator 0 1 1 2% 
Family or partner 3 1 4 9% 
Begging, hustling 5 6 11 24% 
Unknown 1 0 1 2% 
Drug use 
Duration using drugs, mean years 
(SD) 7.8 (4.9) 9.1 (6.3) 8.5 (5.6) - 
Duration injecting, mean years (SD) 3.3 (2.6) 2.0 (2.0) 2.6 (2.5) - 
Main drugs used 
Heroin 11 1 12 27% 
Heroin, and other drugs 11 15 26 58% 
Cocaine 1 3 4 9% 
Cocaine and other drugs  1 2 3 6% 





Table 3. Current contraceptive use among study participants 
 
 







5 1 6 13% 
Calendar 
 
1 0 1 2% 
Implant 
 
2 0 2 4% 
Herbal 
 
1 0 1 2% 
None 
 
13 18 31 69% 
Injection 
 
1 2 3 7% 
Unknown   1 0 1 2% 
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To prevent suffering of 
their child 
If I get pregnant I cannot accept to 
give birth. The way I suffered with 




Because children should be planned, 
because you are not supposed to 
come to earth to suffer, it is very sad 
(Participant # 1, Kilifi). 
Interest in own 
health  
Perception of own 
health while using drugs 
You can’t get pregnant and then take 
care of the child when you are still 
smoking, you wouldn’t have enough 
energy so you have to protect your 
health (Participant # 5, Kilifi). 
 
To prevent HIV 
and STIs 
To prevent HIV 
transmission to unborn 
child 
If you have [HIV]…you are asked 
which method you want, and you are 
then given there and then (Participant 
# 5, Kilifi). 
  
To prevent acquisition 
of other diseases  
I am using it to protect from diseases 





Peers and outreach as 
sources of information 
They are helping us with condoms, 
and they educate us sometimes 




information Low awareness 
Family planning? Those things I 




Influence by partner 
I have a husband…he hasn’t allowed 
me to use, because he is not satisfied 
with one baby (Participant # 8, 
Kilifi). 
Own desire to get 
pregnant 
I am in relationship that I would have 
liked to have a child so at the 
moment I am not using any method 
of prevention (Participant # 7, 
Mombasa). 
Side effects Side effects 
Blood pressure came up, then I was 






I haven’t yet got pregnant with him; I 
don’t know what it is (Participant # 
4, Mombasa). 
Convenience 
and cost of 
health services 
Delay in health services 
Since I had “arosto” [ withdrawal] 
and could not queue, I just left 
(Participant # 10, Mombasa). 
Cost 
There is a time we lack the condoms 
that are given for free, you are forced 
to buy if you have money to buy 
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(Participant # 8 Mombasa).  
 
